Health - Google News: FDA Rejects Bone Drug Bid for Metastasis Prevention - MedPage Today

Health - Google News Google News

FDA Rejects Bone Drug Bid for Metastasis Prevention - MedPage Today Apr 27th 2012, 20:35 RTT News FDA Rejects Bone Drug Bid for Metastasis Prevention MedPage Today By Charles Bankhead, Staff Writer, MedPage Today WASHINGTON -- The FDA has turned down an application to expand indications for denosumab (Xgeva) to include prevention of bone metastases in men with castration-resistant prostate cancer. FDA Rejects Amgen's Application for New Xgeva UseLos Angeles Business Journal FDA blocks Amgen's bid to broaden use of Boulder-made drug XgevaDenver Business Journal FDA rejects Amgen's application for XgevaReuters Sacramento Bee -Medscape -FiercePharma all 37 news articles »

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

Posted in: